Muscle Pharm Corporation (MSLPQ)

[Carlgetsmoked]

Its times like these that i think this applies to Drexler vs Pyatt so well. Thank you Mr. Walken for the audio and the visual.

Two little mice fell in a bucket of cream. The first mouse quickly gave up and drowned. The second mouse, wouldn't quit. He struggled so hard that eventually he churned that cream into butter and crawled out. Gentlemen, as of this moment, I am that second mouse.

[turokman]

Told you

[stupified777]

This thing will run with so little buying. Unreal. $mslp

[MikeyInTheD]

It’s time to buy. I’ve bashed this stock all the way down to .35 and said it could be a buyout target at .25. Never did I expect to buy shares about $1.25…but I’ve bought the past 3 days.

[Hunterdog]

Damn. Almost bought back in yesterday but alas, held off too long. Nice move.

[turokman]

Every dog has its day

$mslp

[Stock_Dog]

http://irdirect.net/prviewer/release_only/id/4755230

[SLC-JD]

Volume is definitely the key here.

It will be interesting to see how much (if any) of today's spike (and accompanying volume) was organic, and how much was MMs stairstepping the PPS upwards. Hoping more of the former.

I still have a hard time predicting how this one will land. For the first time since Drex became involved, it seems like the company is taking tangible steps to improve its position. At the same time, there are definitely obstacles (perhaps not as many or as horrible as this board makes them out to be, but they definitely exist).

[MikeyInTheD]

That’s not a big leap given the momentum. Once volume returns people will chase. Look at stocks like APPS and CELH. I got into both of those under $2 a couple years ago. Now both are over $60. Those aren’t massive companies with billions in revenue. They are still small companies who make a few pennies per share in profit. I see no reason why MSLP can’t follow that same path.

I agree - most people throw out big numbers without an rationale of how they get to their estimate that says the stock will go up 15x. The sweet spot in stocks is finding those that can go from $1-$3 range to $25+. You don’t make a lot with Apple going up a dollar a share - but if MSLP goes up a dollar a share we are all a bit richer.

[Stock_Dog]

25!! I’m not hating but damn.

[MikeyInTheD]

It’s time to load up. I rode this up a few years ago and bailed as they cut back most of their SKUs. The original energy drink tasted amazing and gave great energy. I hope they bring back the same formula.

This could cross $25 in the next 18 months.

[SLC-JD]

It looks like they really are committed to this new line:

https://www.otcmarkets.com/stock/MSLP/news/MusclePharm-Closes-Four-More-Distributors-for-MP-Performance-Energy-Line?id=305416

[turokman]

Have you not been paying attention to what’s been going on ? 3 profitable quarters in a row . Drexler has shown that he can get the job done . Cut the top line to focus on bottom line . So what if growth has stalled if the company is now solvent . Have you paid attention to the recent hire of the Yum! brands and Rockstar execs ? This is an all-star team that Drexler has put together.

Go spread your fear tactics elsewhere .

[turokman]

More fraud allegations after the stock just had a 1300% run ? I told you that I was right on this stock and that when you called for imminent bankruptcy when it traded as low as 0.04 .

I loaded the boat at 0.09. Locked in profit and Still holding a majority of my holdings . Guess I was right after all on this one .

$MSLP

[Madcowelixir]

It is likely Ryan is refusing to show the books and records to the judge in the WW case because it would open him up to criminal fraud as the books were cooked as he desperately attempts to throw his former college roommate Brian Cassuto under the bus as well as auditors Plante and Moran.

[SLC-JD]

Not doubting, but curious which case that is? It looks like the NV casees are closed (and I haven't looked at the CA cases yet), but I know there were actions in other jurisdictions as well. Was this contempt for a failure to show cause, or something else?

[Madcowelixir]

Hilarious

Ryan is refusing to show the financials to the judge in the White Winston suit and has been fined $1,500 in Q1. What to hide? The bogus numbers and the revolving door of CFOs of which several have lost the CPA credentials for malfeasance.

[Madcowelixir]

Disaster strikes again.

Sales down another -25% and now at $13m per Q.

Decline is accelerating and MSLP total sales have now fallen BELOW $1m a week for the first time in 10 years.

Fun Fact: It now takes CEO Drexler 90 days to sell what CEO Brad sold in 21 days.

Cash on Hand down to $500K after burning $2m since last Q.

Just shylock Debt outstanding dwarfs total assets....not counting the lawsuit settlement payments and AR v AP deficit.

Outstanding Shares explodes to almost 45.5m after another 13m shares of dilution since last Q.

[turokman]

$$$$$ $MSLP

[SLC-JD]

An actual earnings call! Now *that* is a pleasant surprise!

[turokman]

MusclePharm to Announce First Quarter 2021 Financial Results on Monday, May 24, 2021

MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, announced today that the Company will report its financial results for the first quarter ended March 31, 2021, after the market closes on Monday, May 24, 2021.

The Company will host a conference call to discuss its operating results on Monday, May 24, 2021, at 1:30 pm Pacific Time (4:30 pm Eastern Time). Investors interested in accessing the live call can dial [phone] from the U.S. and International callers can dial [phone]. A telephone replay will be available following the event and can be accessed by dialing [phone] from the U.S. and International callers can dial [phone]; the conference ID is 13719996.

[SLC-JD]

15 days.

It'll be interesting to see if they really have turned the page, or if they go back to stop sign.

also curious what happened with their QB application. It's been four months, and they're still trading Pink.

[MakeItRain88]

How long does that give them?

[SLC-JD]

An NT. Shocker.

[turokman]

MusclePharm taps former Rockstar Energy executive to build National Distribution Network and Sales Team for MP Performance Energy beverages

CALABASAS, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, today announced a partnership with former Rockstar executive, Joe Cannata. Together, they will be creating a fully functional energy drink line, MP Performance Energy, under the MusclePharm and FitMiss brand(s) and building out the national distribution network. MP Performance Energy will launch in the summer of 2021 with three incredible products: Combat/Grapefruit Lime, Shred/Green Apple and Wreckage/Fruit Punch.

Mr. Ryan Drexler, the Chairman of the Board and Chief Executive Officer of MusclePharm, stated, “In the past, MusclePharm has attempted to enter the functional energy drink arena, but the timing and the team were never quite right. With this new partnership, MusclePharm will be working with a top industry veteran who understands the space inside and out, and I believe the partnership will help elevate the MusclePharm brand and facilitate new growth. Mr. Cannata will build the distribution network and sales force for MP Performance Energy, and additional seasoned beverage executives will be named to the team soon.”

Mr. Drexler continued, “I’m confident that this will be the ultimate partnership as we work to leverage MusclePharm’s current distribution network and industry contacts, and I know these first three drinks are only the beginning of an exciting new venture. Over the next twelve months our goal is to add numerous SKUs to an ever-growing category. As we move forward, and as MusclePharm’s growth continues to attract new great talent, I passionately believe we’ll see that we are just scratching the surface of MusclePharm’s true potential.”

“MusclePharm is already a clear leader in the Fitness Supplements space with an established name and strong brand recognition. I see the brand as a natural fit to be extended into the functional energy category. Additionally, I see a huge opportunity with the FitMiss product line, a female focused offering, directly targeting a consumer that, in my opinion, has been overlooked for many years in the energy space,” stated Mr. Cannata. “Early Distributor and Retailer feedback has been incredibly positive, and I am highly confident we have the right proposition to successfully lead MusclePharm into beverages. I will have forthcoming announcements regarding distributor alignments, retailer listings, and personnel additions. With Ryan’s vision and my experience, I have complete confidence that MusclePharm and FitMiss will quickly become a key player in the functional energy space and beyond.”

https://www.musclepharmcorp.com/prviewer/release_only/id/4726578

[turokman]

MusclePharm posts milestone: First profitable year in company's history

02-Apr-2021 By Hank Schultz

Long suffering sports brand MusclePharm gave signs of finally turning a corner with its year end statement that reported a profit even as sales fell year over year.

HTTPS://WWW.NUTRAINGREDIENTS-USA.COM/ARTICLE/2021/04/02/MUSCLEPHARM-POSTS-MILESTONE-FIRST-PROFITABLE-YEAR-IN-COMPANY-S-HISTORY

[turokman]

Great piece of due diligence you posted last Sept . The stock has been on an incredible run since, nearly a 10 bagger .

Every dog has its day !

[turokman]

MusclePharm Slams Home First Profitable Year in Company History | Consumed Ep.118

Great video on Joshua Shall who has been covering this stock since it was in the 0.20’s .

[turokman]

Sabina Rizvi, a former Yum! Brands C-suite executive, joins MusclePharm as President and Chief Financial Officer

CALABASAS, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition and lifestyle branded nutritional supplements, announced today that its Board of Directors has named Sabina Rizvi as its first President and Chief Financial Officer. Rizvi is an inspirational commercial leader who successfully shapes strategy, structure and culture to grow strong, relevant brands.

https://www.globenewswire.com/news-release/2021/04/08/2206653/0/en/Sabina-Rizvi-a-former-Yum-Brands-C-suite-executive-joins-MusclePharm-as-President-and-Chief-Financial-Officer.html

[SLC-JD]

Being a CFO at MSLP has about as much job security as being a drummer for Spinal Tap.

[turokman]

What a great week !! Every dog has its day !! $MSLP

[turokman]

MusclePharm Announces Record Breaking Fourth Quarter and Fiscal Year
2020 Financial Results; Primed for Return to Growth

Full Year Gross Margins Improve over 1,900 basis points to 30%

Operating Expenses Decline $6.8 million or over 29%

Plans to Leverage Leading Brand by Entering New Categories to return to Growth

CALABASAS, Calif., March 30, 2021 (GLOBE NEWSWIRE) — MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, today reported financial results for the fourth quarter and the fiscal year ended December 31, 2020.

Ryan Drexler, President and Chief Executive Officer, stated, “Despite 2020 being a challenging year due to Covid-19, we executed at the highest level achieving strong results by turning a profit for the first time in our Company’s history. We reduced operating expenses by 29%, expanded our gross margins to over 30% and strategically expanded our omni-channel strategy by increasing penetration with our largest online customers. Our results this year are a testament to the turnaround strategy we set forth two years ago to dramatically restructure MusclePharm and increase our focus on profitability, and I’m incredibly proud of the hard work put forth by the entire MusclePharm team.”

Mr. Drexler continued, “We have one of the strongest brands in the health and fitness industry and are very optimistic that we will continue to turnaround our business in 2021 by focusing on higher margin channels, offering customers products where they prefer to shop, improved cost containment and implementing additional pricing controls. Our Company is well known for providing superior products and we expect new distribution and brand expansion opportunities that will enable us to generate long-term profitable growth.

The following are key financial highlights for the period. Reconciliations of certain GAAP to non-GAAP measures are provided later in this press release.

Fourth Quarter 2020 Compared to Fourth Quarter 2019

? Revenue, net was $15.1 million compared to $17.4 million.
? Gross margin improved to 31.7% compared to 14.4%.
? Net income was $2.8 million compared to a net loss of $(3.5) million.
? Diluted income per share was $0.06 compared to diluted loss per share of $(0.11).
? Adjusted EBITDA was $0.9 million compared to negative Adjusted EBITDA of $(2.6) million.




Fiscal Year 2020 Compared to Fiscal Year 2019

? Revenue, net was $64.4 million compared to $79.7 million.
? Gross margin improved to 30.4% compared to 10.9%.
? Net income was $3.2 million compared to a net loss of $(18.9) million.
? Diluted income per share was $0.08 compared to diluted loss per share of $(0.92).
? Adjusted EBITDA was $3.3 million compared to negative Adjusted EBITDA of $(14.3) million.

Non-GAAP Financial Measures

Within this press release, the Company makes reference to a non-GAAP financial measure (Adjusted EBITDA), which has a directly comparable GAAP financial measure (net income). EBITDA is defined as net income/(loss) excluding interest, income taxes and depreciation and amortization. Adjusted EBITDA, in addition to those amounts included in EBITDA, is further adjusted for items such as stock-based compensation and gain or loss on disposal of property and equipment and gain on settlement of payables.

EBITDA is provided so that investors have the same financial data that management uses to assess the Company’s operating results with the belief that it will assist the investment community in properly assessing the ongoing performance of the Company for the periods being reported and future periods. The presentation of this additional information is not meant to be considered a substitute for measures prepared in accordance with GAAP.

Forward-Looking Statements

Information provided and statements contained in this press release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995. Forward-looking statements include information concerning the Company’s strategy and expansion of its product portfolio. Such forward-looking statements only speak as of the date of this press release and the Company assumes no obligation to update the information included in this press release. Statements made in this press release that are forward-looking in nature may involve risks and uncertainties. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees and are subject to certain risks, uncertainties and assumptions that are difficult to predict, including, without limitation, risks relating to consumer spending may decline or that U.S. and global macroeconomic conditions may worsen resulting in reduced demand for the Company’s products, risks relating to changes in consumer preferences away from the Company’s offerings, risks relating to the effectiveness and efficiency of the Company’s advertising campaigns and marketing expenditures, including existing brands and the launch of new brands, which may not result in increased revenue or generate sufficient levels of brand name and program awareness, risks if the Company becomes subject to health or advertising related claims from its customers, competitors or governmental and regulatory bodies, and risks relating to increased competition from other nutrition providers.

For further details and a discussion of these risks and uncertainties, see the Company’s periodic reports, including the annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, filed with or furnished to the Securities and Exchange Commission and available at www.sec.gov. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the results of any revisions to the forward-looking statements made in this press release.

About MusclePharm, Inc.

MusclePharm® is an award-winning, worldwide leading sports nutrition & lifestyle company offering branded nutritional supplements. Its portfolio of recognized properties include the MusclePharm® Sport Series, Essentials Series, and recently-launched Natural Series, as well as FitMiss™ – a product line designed specifically for female athletes. MusclePharm® products are available in more than 100 countries globally, with its Combat Protein product lineup being the company’s most popular.

Contact:
John Mills, Managing Partner
ICR, Inc.
646-277-1254
[e-mail]

[turokman]

Stock market ?? seems to like it. Guess I was right after all this time around my friend. Steak dinner on me tonight buddy .

[Madcowelixir]

all non cash again. Another $1.7m non cash "profit" on losing two lawsuits in addition to a few other fake non cash balance sheet gyrations.

Real interesting number is borrowing from Prestige went up $5m in Q4 over Q3. MSLP borrowed another $5m to cover the real cash losses and cash on hand barely moved up and inventory is the same.

Why is MSLP borrowing an additional $5m in 90 days if it is so profitable? Almost $2m a month in additional borrowings at shylock interest rates and none of it hits cash on hand or inventory. These are real cash losses.

[turokman]

10-K out ... 3 million in operating profit for 2020!! Nice $MSLP

Gross margins improved to 30% (2020) from 11% (2019 )

https://www.sec.gov/Archives/edgar/data/1415684/000149315221007088/form10-k.htm

[SLC-JD]

Looks like Drex sold enough used equipment and shelving to pay his property taxes.

[turokman]

As crazy as this sounds , This stock Could benefit as ‘ flight to value ‘ as this has always been a real product / brand with sales now going cash flow positive. $2 is not out of the realm of possibilities here.

[Madcowelixir]

First of all you need a math refresher course. MSLP has posted $49m of revenue through Q3 2020.

Secondly, there is lots of volume at $.12 cents today.

MSLP CAN'T even post a profit with ZERO expense for brick and mortar, Research and Development and Marketing and Advertising.

MSLP's fake profit in Q3 was due to one time gains for selling all the physical assets when they closed the HQ and Distribution WH and playing Inventory Valuation games that are fake and taking a huge fake gain on losing a lawsuit for not paying a supplier millions owed.

I love how Ryan put his longtime Hollywood party buddy (Heller) on the board as chief of compensation committee after getting pushback from a long time independent board member on executive compensation and the hypers here think it is great news. Too funny.


Drexler and Heller

[SLC-JD]

acknowledging fundamentals, a lack of real news, and a prolonged dark period...

MSLP is theoretically 'current' (although the timeliness of their filings and the 'current' checkboxes admittedly makes this a bit confusing for some), and as of 09/20 had $57MM in revenues, has a *professional PR firm*, yet it couldn't generate more than $570.00 in trading activity today.

Meanwhile, another company I'm long in has had zero disclosure since 2018, hasn't paid its OTC bill and so is listed as 'defunct', and has blown multiple self-imposed deadlines to cure all the above, yet manages tens of thousands in trading on a daily basis.

[Stock_Dog]

Who bought today ?

[Carlgetsmoked]

You love to see it

[turokman]

Barchart Technical Opinion for Muscle Pharm Corp (MSLP)

Overall Average:
100% BUY
Overall Average Signal calculated from all 13 indicators. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal.

https://www.barchart.com/share/widget/1611515057_832116991//stocks/quotes/MSLP/opinion?t=Barchart%20Technical%20Opinion%20for%20Muscle%20Pharm%20Corp%20(MSLP) via @Barchart

[turokman]

Drexler has recently said that he is open to being part of a larger platform . Nike would be huge .

[Jimmy Swaggert]

That would have worked but MSLP had their hands in too many pots.

[MakeItRain88]

I always thought Nike should buy MSLP to enter the market.

[MakeItRain88]

Love seeing the MP logo when watching old fights tho.

[MakeItRain88]

Small steps. Lol

[Jimmy Swaggert]

MSLP needs the UFC again. Those were the days!

[turokman]

MusclePharm Appoints Marketing Executive to Its Board of Directors

CALABASAS, Calif., Jan. 21, 2021 (GLOBE NEWSWIRE) -- MusclePharm Corporation (OTCMKTS: MSLP), a global provider of leading sports nutrition & lifestyle branded nutritional supplements, today announced that it has appointed Michael Heller to its Board of Directors.

Michael Heller, Principal of Talent Resources Holdings, is a marketing visionary in the world of influencer, celebrity, athlete and social media marketing. He has become a leading industry voice, having appeared in such major outlets as CNBC, Business Insider, Fortune, Fox Business, Buzzfeed, CNN, Digiday, The Hollywood Reporter, Vanity Fair and many others. With over 25 years of experience, Michael has conceived and produced some of the most high-profile events and activations in the country, including the annual Sports Illustrated Super Bowl party. From working with A-listers, such as Kylie Jenner, to professional athletes, such as Kyle Kuzma, Michael has a passion for connecting brands with the right talent for high impact marketing campaigns that yield big results. Amidst the COVID-19 pandemic, Michael has continued to grow the Talent Resources presence by opening offices in London, Dubai and Chicago, while continuing to expand in Boston, Los Angeles and New York.

Ryan Drexler, President and Chief Executive Officer, stated, “We are pleased to welcome Michael as a new independent director. We look forward to benefiting from his valuable marketing perspective and breadth of expertise of dramatically expanding brand awareness through many different avenues. He joins MusclePharm at an exciting time as we continue to drive our omni-channel strategy and build deeper relationships and expand our portfolio of product offerings through strategic marketing and innovation."

"I am excited to join the board of a leading health living brand," commented Michael Heller. "I look forward to working alongside my fellow Board members and company management to advance our offerings and enhance our marketing opportunities to ensure our leading offerings are achieving their full potential.”

The Company has made significant cost improvements in many facets of its business. As reported in the Company’s most recent Annual Report on Form 10-K for the year ended December 31, 2019, Director compensation was in excess of $300,000 for each of its two non-employee Directors. This amount is anticipated to decrease by more than 50% for 2021

$MSLP

https://www.globenewswire.com/news-release/2021/01/21/2162237/0/en/MusclePharm-Appoints-Marketing-Executive-to-Its-Board-of-Directors.html

[turokman]

Nice buy ! $mslp